Antimicrobial lipids in nano-carriers for antibacterial delivery

J Drug Target. 2020 Mar;28(3):271-281. doi: 10.1080/1061186X.2019.1681434. Epub 2019 Oct 24.

Abstract

Antimicrobial lipids have been recognised as broad-spectrum antibacterial agents. They can directly act on and lyse bacterial cell membrane, and inhibit bacterial growth through a range of mechanisms. Antimicrobial lipids include free fatty acids, monoglycerides, cholesteryl ester, sphingolipids and etc., with the first two being the most extensively studied. Their application is usually hindered by the low solubility of the compounds themselves, and nano-sized lipid-based carriers can endow druggability to these antimicrobial agents for they improve lipid solubility and dispersion in aqueous formulations. Nano-carriers also possess advantages in overcoming drug resistance. In this review we will discuss different kinds of antimicrobial lipids in nano-sized carriers for antibacterial delivery. CAL02 as a promising infection-controlling liposome consisted of cholesterol and sphingomyelin will also be included for it's a unique anti-infection approach, which signifies that the underlying antibacterial roles antimicrobial lipids needs to be further addressed. With the global emergence of antibiotic resistance, antimicrobial lipids formulated in nano-carriers might provide a novel alternative in combatting infectious diseases.

Keywords: Antimicrobial lipids; CAL02 liposomes; antibacterial activity; nano-carriers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Drug Carriers / chemistry*
  • Drug Delivery Systems
  • Drug Resistance, Bacterial
  • Humans
  • Lipids / chemistry*
  • Nanoparticles
  • Particle Size
  • Solubility

Substances

  • Anti-Bacterial Agents
  • Drug Carriers
  • Lipids